Results 81 to 90 of about 454 (136)

Towards the Cure of CML by the Molecular Approach Strategy [PDF]

, 2012
Antonia Cagnetta, Franco Patrone, Marco Gobbi, Michele Cea   +3 more
core   +2 more sources

Local Recurrence Following Total Marrow Radiation: Implications for Clinical Target Delineation. [PDF]

Cureus, 2020
Hara JH, Ahn KH, Aydogan B, Koshy M.
europepmc   +1 more source

New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges. [PDF]

Cancers (Basel), 2021
Allegra A, Pioggia G, Innao V, Musolino C, Gangemi S.   +4 more
europepmc   +1 more source

New insights into the generation and function of megakaryocytes in health and disease. [PDF]

Haematologica
Du C, Chen J, Wang J.
europepmc   +1 more source

Pharmaceutical Advances and Proteomics Researches. [PDF]

Iran J Pharm Res, 2019
KhalKhal E, Rezaei-Tavirani M, Rostamii-Nejad M.   +2 more
europepmc   +1 more source

Hematopoietic Stem Cells in Chronic Myeloid Leukemia [PDF]

, 2013
Avilés-Vázquez, Sócrates, Chávez-González, Antonieta, Mayani, Héctor, Moreno-Lorenzana, Dafne   +3 more
core   +1 more source

Prevalence and clinical characteristics of chronic kidney disease among patients with newly diagnosed ketosis-onset diabetes. [PDF]

World J Diabetes
Li MH, Xu MR, Wang YJ, Shen L, Chen MY, Li LX.   +5 more
europepmc   +1 more source

Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK. [PDF]

Commun Biol
Huang CY, Chung YH, Wu SY, Wang HY, Lin CY, Yang TJ, Fang JM, Hu CM, Chang ZF.   +8 more
europepmc   +1 more source

Long non-coding RNA H19 as a prognostic biomarker for oral squamous cell carcinoma. [PDF]

Front Med (Lausanne)
Kumar K, Hallikeri K, Oli AK, Radder K, Jain A, Shilpasree AS, Dhanapal R, Tabnjh AK, Selvaraj S.   +8 more
europepmc   +1 more source